Literature DB >> 17325175

A novel isoform of acetylcholinesterase exacerbates photoreceptors death after photic stress.

Rinat Kehat1, Esther Zemel, Nicolas Cuenca, Tama Evron, Debra Toiber, Anat Loewenstein, Hermona Soreq, Ido Perlman.   

Abstract

PURPOSE: To study the involvement of stress-induced acetylcholinesterase (AChE) expression in light-induced retinal damage in albino rats.
METHODS: Adult albino rats were exposed for 24 hours to bright, damaging light. AChE expression was monitored by in situ hybridization, by histochemistry for AChE activity, and by immunocytochemistry. An orphan antisense agent (Monarsen; Ester Neurosciences, Ltd., Herzlia Pituach, Israel) was administered intraperitoneally to minimize light-induced AChE expression. The electroretinogram (ERG) was recorded to assess retinal function.
RESULTS: Twenty-four-hour exposure to bright light caused severe reduction in the ERG responses and augmented expression of mRNA for the "read-through" variant of AChE (AChE-R) in photoreceptor inner segments (IS), bipolar cells, and ganglion cells. AChE activity increased in IS. The expressed AChE protein was a novel variant, characterized by an extended N terminus (N-AChE). Systemic administration of the orphan antisense agent, Monarsen, reduced the photic induction of mRNA for AChE-R, and of the N-AChE protein. Rats exposed to bright, damaging light and treated daily with Monarsen exhibited larger ERG responses, relatively thicker outer nuclear layer (ONL), and more ONL nuclei than did rats exposed to the same damaging light but treated daily with saline.
CONCLUSIONS: The findings indicate that the photic-induced novel variant of AChE (N-AChE-R) may be causally involved with retinal light damage and suggest the use of RNA targeting for limiting such damage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17325175     DOI: 10.1167/iovs.06-0847

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Inhibition of miR-134 Protects Against Hydrogen Peroxide-Induced Apoptosis in Retinal Ganglion Cells.

Authors:  Yi Shao; Yao Yu; Qiong Zhou; Cheng Li; Lu Yang; Chong-Gang Pei
Journal:  J Mol Neurosci       Date:  2015-03-06       Impact factor: 3.444

2.  Trans-acting factors governing acetylcholinesterase mRNA metabolism in neurons.

Authors:  Lucas M Bronicki; Bernard J Jasmin
Journal:  Front Mol Neurosci       Date:  2012-03-22       Impact factor: 5.639

3.  Acetylcholinesterase involvement in apoptosis.

Authors:  Xue-Jun Zhang; David S Greenberg
Journal:  Front Mol Neurosci       Date:  2012-04-10       Impact factor: 5.639

4.  Acetylcholinesterase (AChE) is an important link in the apoptotic pathway induced by hyperglycemia in Y79 retinoblastoma cell line.

Authors:  R Shehadeh Masha'our; R Heinrich; H J Garzozi; I Perlman
Journal:  Front Mol Neurosci       Date:  2012-06-06       Impact factor: 5.639

5.  Stressing hematopoiesis and immunity: an acetylcholinesterase window into nervous and immune system interactions.

Authors:  Adi Gilboa-Geffen; Gunther Hartmann; Hermona Soreq
Journal:  Front Mol Neurosci       Date:  2012-03-16       Impact factor: 5.639

6.  ATF3 Regulates the Expression of AChE During Stress.

Authors:  Ronit Heinrich; Rivka Hertz; Esther Zemel; Irit Mann; Liat Brenner; Amir Massarweh; Shai Berlin; Ido Perlman
Journal:  Front Mol Neurosci       Date:  2018-04-06       Impact factor: 5.639

7.  N-acetylcholinesterase-induced apoptosis in Alzheimer's disease.

Authors:  Debra Toiber; Amit Berson; David Greenberg; Naomi Melamed-Book; Sophia Diamant; Hermona Soreq
Journal:  PLoS One       Date:  2008-09-01       Impact factor: 3.240

8.  Readthrough acetylcholinesterase (AChE-R) and regulated necrosis: pharmacological targets for the regulation of ovarian functions?

Authors:  J Blohberger; L Kunz; D Einwang; U Berg; D Berg; S R Ojeda; G A Dissen; T Fröhlich; G J Arnold; H Soreq; H Lara; A Mayerhofer
Journal:  Cell Death Dis       Date:  2015-03-12       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.